Conseil consultatif sur la recherche (CCR)


PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output

In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

Alison Allan,Western University, London, ON
David Berman, Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, Ontario Institute for Cancer Research (OICR), Toronto
, ON
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC

Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Masoom Haider, Mount Sinai Hospital, Toronto, ON
Anne Katz, Manitoba Prostate Centre, Winnipeg, MB
Winston Klass, représentant de la communauté, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Mathieu Lupien, Princess Margaret Cancer Centre, Toronto, ON
Randy Mellow, représentant de la communauté, Peterborough, ON

Cynthia Ménard, Centre hospitalier de l'Université de Montréal, Montreal, QC
Ian G.Mills, Queen's University Belfast, Belfast, UK
Fred Saad, Université de Montréal, Montreal, QC
Gurmit Singh (président), McMaster University, Hamilton, ON

Danny Vesprini, Sunnybrook Research Institute, Toronto, ON
Katherine Zukotynski, McMaster University, Hamilton, ON

28 juin, 2018


 



Inscrivez-vous à nos nouvelles

* obligatoire






 
Contenu en vedette
Des travaux de recherche se concentrent sur les hommes homosexuels et bisexuels atteints d’un cancer de la prostate

Vancouver, 25 septembre 2018 – La recherche financée par Cancer de la Prostate Canada ouvre la voie à l’amélioration de la qualité de vie des hommes ayant des rapports sexuels avec des hommes (HSH1) dans la communauté LGBTQ2+.
plus

Cancer de la Prostate Canada lance le premier programme national sur la thérapie par radionucléides

Toronto, 27 juin 2018 – Les chercheurs canadiens donnent le ton à l’avenir des traitements pour les hommes atteints de cancer avancé de la prostate au pays grâce à une nouvelle subvention de Cancer de la Prostate Canada financée par la Fondation Movember.
plus


Cancer de la prostate nouvelles